NORTHWEST BIOTHERAPEUTICS INC Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Northwest Biotherapeutics Inc quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Northwest Biotherapeutics Inc Operating Lease, Payments for the quarter ending March 31, 2024 was $241K, a 7.11% increase year-over-year.
  • Northwest Biotherapeutics Inc annual Operating Lease, Payments for 2023 was $846K, a 6.93% decline from 2022.
  • Northwest Biotherapeutics Inc annual Operating Lease, Payments for 2022 was $909K, a 4.97% increase from 2021.
  • Northwest Biotherapeutics Inc annual Operating Lease, Payments for 2021 was $866K, a 12.8% decline from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $846K -$63K -6.93% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $909K +$43K +4.97% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $866K -$127K -12.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 $993K +$749K +307% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $244K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.